We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cytokine Signature Helps Target Advanced Breast Cancer

News   Sep 24, 2018 | Original story by Joyce Dall'Acqua Peterson for The Jackson Labroatory

 
Cytokine Signature Helps Target Advanced Breast Cancer

Human breast cancer tissue stained by immunofluorescence illustrates the interplay between secreted and surface-bound TGFβ (red) expressed by cancer cells (blue), which primes tumor-infiltrating myeloid cells to produce IL1β (green). This in turn will lead to chronic inflammation associated with breast cancer progression. Gray, nuclei. Credit: Jackson Laboratory

 
 
 

RELATED ARTICLES

$27 Million Grant Focuses on the Future of Biomanufacturing

News

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

READ MORE

Treating Blood Cancers With a Low-cost Arthritis Drug

News

A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers, according to a new study by the University of Sheffield.

READ MORE

Transporting an Anti-cancer Agent to Cells Using Nanoparticles

News

Metal-organic frameworks (MOFs) could be used as a platform for delivering a potent anti-cancer agent, called siRNA, to cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE